skip to Main Content

About
Research
Our Team
News Center
Search

Search

Atezolizumab Improves Survival vs Docetaxel in Advanced Non-Small-Cell Lung Cancer

March 17, 2016
ncalresearch
0 Comments

Share This

Twitter
Facebook
LinkedIn
Email

ncalresearch

Related Items

HbA1c may overestimate mean glucose for some Black patients with diabetes

Actually, Alcohol Use Might Not Increase Breast Cancer Recurrence Risk

Kaiser Permanente’s AI approach puts patients and doctors first

This Post Has 0 Comments

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Name *

Email *

Website

Comment *

Δ

KP Research Radio Podcasts

Predicting psychosis risk to reduce its burden
Syndemics: Going deep on HIV and heart health
Metabolomics: Seeking clues for healthier pregnancies

View All Podcasts

previous post: Average Life Expectancy For People in HIV Care Still Falls Far Short
next post: HIV Complications: What Happens to Your Body

About

About DOR
Annual Report
60 Years of Innovation
Health Equity
History
Our Founder
Contact Us

Our Team

Leadership Team
Research Scientists
Scientific Sections
Adjunct Investigators

Our Research

Our Research
Behavioral Health and Aging
Biostatistics
Cancer
Cardiovascular and Metabolic Conditions
Health Care Delivery and Policy
Infectious Diseases
Women’s and Children’s Health

Research Opportunities

Fellowship Programs
Research Careers
Partnerships
Research Consultation and Collaboration

News Center

News Center
Research Spotlight
KP Research Radio Podcasts
In the News
Media Contacts

Visit Our Other Sites

Kaiser Permanente (kp.org)
Careers at Kaiser Permanente
aboutKP (Kaiser Permanente news)
LookInside KP
The Permanente Medical Group

Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3400

Privacy Policy | Terms and Conditions

Follow us on these external social media sites that will open in a new browser window.

Facebook
Twitter
Linked In

© 2023 Kaiser Permanente Division of Research

Search